Drugs / LAS106521
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT00991861 Comparator | Aug 2009 → Feb 2010 | actinic keratosis | Almirall, S.A. | Completed | No outcome recorded |
| Phase 3 | NCT00987246 Comparator | Jun 2008 → Jun 2009 | actinic keratosis | Almirall, S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LAS106521 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00987246 ↗ |
| Route | Topical | “Topical” NCT00987246 ↗ |